Advances in Virus Research

Advances in Virus Research (eBook)

eBook Download: PDF | EPUB
2009 | 1. Auflage
292 Seiten
Elsevier Science (Verlag)
978-0-08-092170-9 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
137,00 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Published since 1953, Advances in Virus Research covers a diverse range of in-depth reviews providing a valuable overview of the current field of virology.

The impact factor for 2006 is 3.48 placing it 7th in the highly competitive category of virology.

* Contributions from leading authorities
* Informs and updates on all the latest developments in the field
Published since 1953, Advances in Virus Research covers a diverse range of in-depth reviews providing a valuable overview of the current field of virology. The impact factor for 2006 is 3.48 placing it 7th in the highly competitive category of virology. Contributions from leading authorities Informs and updates on all the latest developments in the field

Front Cover 
1 
Advances in Virus Research 4
Copyright Page 
5 
Contents 
6 
Chapter 1: The History and Evolution of Human Dengue Emergence 8
I. Introduction to Flaviviruses 9
II. Dengue Viruses 12
III. Dengue Epidemiology 15
IV. Evolution 36
V. Potential for Sylvatic Denv Reemergence 49
Acknowledgments 62
References 62
Chapter 2: Third-Generation Flavivirus Vaccines Based on Single-Cycle, Encapsidation-Defective Viruses 84
I. Introduction 85
II. Currently Licensed Vaccines for Flavivirus Diseases 90
III. Promising Vaccine Candidates in Development 95
IV. Replication-Defective and Single-Cycle Virus Vaccines 111
V. Conclusion and Perspectives 119
Acknowledgments 119
References 120
Chapter 3: Swine Influenza Viruses: A North American Perspective 134
I. Introduction to Influenza A Viruses 135
II. Evolution of North American SI Viruses of the H1 and H3 Subtype 139
III. Cross-Species Transmission of Influenza Aviruses and Novel Subtypes in North American Swine 143
IV. Vaccination of Pigs Against SI 146
V. Conclusions and Outlook 154
Acknowledgments 155
References 155
Chapter 4: Replication and Partitioning of Papillomavirus Genomes 162
I. Background 163
II. Replication Initiation 168
III. Maintenance Replication 179
IV. Vegetative Replication 191
V. Other Aspects of Papillomavirus Replication 193
Acknowledgments 197
References 197
Chapter 5: Rhesus Cytomegalovirus: A Nonhuman Primate Model for the Study of Human Cytomegalovirus 214
I. Introduction 215
II. Background 216
III. Discovery of RhCMV 217
IV. Epidemiology of RhCMV 218
V. Pathogenesis of RhCMV 219
VI. The Coding Capacity of RhCMV 220
VII. Susceptibility of RhCMV to Anti-HCMV Drugs 221
VIII. Host Immunity to RhCMV 222
IX. Modulation of the Host by RhCMV 223
X. Vaccine Studies in Rhesus Macaques 225
XI. Future Directions 227
Acknowledgements 228
References 228
Chapter 6: Drosophila Viruses and the Study of Antiviral Host-Defense 234
I. Introduction 235
II. Sigma Virus 236
III. Drosophila C Virus (DCV) 243
IV. Other Drosophila Viruses 247
V. Antiviral Reactions in Drosophila 256
VI. Conclusion and Perspectives 263
Acknowledgments 265
References 265
Index 274
Color Plates 
281 

Chapter 1

The History and Evolution of Human Dengue Emergence


Nikos Vasilakis; Scott C. Weaver    Center for Tropical Diseases and Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555-0609

Abstract


Dengue viruses (DENV) are the most important human arboviral pathogens. Transmission in tropical and subtropical regions of the world includes a sylvatic, enzootic cycle between nonhuman primates and arboreal mosquitoes of the genus Aedes, and an urban, endemic/epidemic cycle principally between Aedes aegypti, a mosquito that exploits peridomestic water containers as its larval habitats, and human reservoir hosts that are preferred for blood feeding. Genetic studies suggest that all four serotypes of endemic/epidemic DENV evolved independently from ancestral, sylvatic viruses and subsequently became both ecologically and evolutionarily distinct. The independent evolution of these four serotypes was accompanied by the expansion of the sylvatic progenitors' host range in Asia to new vectors and hosts, which probably occurred gradually over a period of several hundred years. Although many emerging viral pathogens adapt to human replication and transmission, the available evidence indicates that adaptation to humans is probably not a necessary component of sylvatic DENV emergence. These findings imply that the sylvatic DENV cycles in Asia and West Africa will remain a potential source of re-emergence. Sustained urban vector control programs and/or human vaccination will be required to control DEN because the enzootic vectors and primate reservoir hosts are not amenable to interventions.

I Introduction to Flaviviruses


Dengue viruses (DENV) are members of the genus Flavivirus in the Family Flaviviridae. Flaviviruses are single-stranded RNA viruses of positive polarity and most, but not all, require hematophagous arthropods (mosquitoes or ticks) to complete their horizontal transmission cycle. They are responsible for a broad spectrum of pathogenic manifestations in humans, domestic animals, and birds (Heinz et al., 2000). Flaviviruses are widely distributed nearly throughout the world, except Antarctica. More than 50% of all known flaviviruses have been associated with human disease and include some of the most important human pathogens, such as Yellow fever virus (YFV), DENV, Japanese encephalitis virus (JEV), and Tick-borne encephalitis virus (TBEV). For example, DENV is responsible for the highest incidence of human morbidity and mortality among all flaviviruses: ca. 100 million infections annually, resulting in approximately 500,000 cases of DEN hemorrhagic fever (DHF) with a case fatality rate of about 5% (Halstead, 1997). The majority of human infections with flaviviruses are asymptomatic, whereas symptomatic infections commonly manifest themselves as a flu-like disease that is characterized by sudden onset of fever, arthralgia, myalgia, retro-orbital headaches, maculopapular rash, leukopenia, vascular leakage, and/or encephalitis (Belov et al., 1995; Burke et al., 1988; Gritsun et al., 2003; Lumsden, 1958; Work et al., 1957). Depending on the flavivirus, the infection may also cause severe encephalitis with lifelong neurologic sequelae (Brinker and Monath, 1980; Charrel et al., 2004), persistent disease (Ravi et al., 1993; Sharma et al., 1991), or even death (McLean and Donohue, 1959; Tsai and Mitchell, 1989; Work et al., 1957). In animals, flavivirus infections occur in a wide range of animals including sheep, cattle, equids, monkeys, muskrats, rodents, bats, birds, and seabirds (Autorino et al., 2002; Clifford et al., 1971; Gritsun et al., 2003; Lanciotti et al., 1999; Lvov et al., 1971; Malkinson and Banet, 2002; Shope, 2003; St George et al., 1977; Swanepoel, 1994; Swanepoel and Coetzer, 1994; Varelas-Wesley and Calisher, 1982). Infection of animals, as in humans, varies from asymptomatic to lethal.

The name flaviviruses comes from the Latin word “flavus,” meaning yellow that signifies jaundice, a common sign of infection with the prototypic Yellow fever virus. The genus Flavivirus includes 56 species (Heinz et al., 2000). Yellow fever virus was among the first filterable agents shown to cause human diseases (along with DENV) (Ashburn and Craig, 1907; Reed and Carroll, 1902), the first virus isolated whose transmission involves the mosquito vector Aedes (Stegomyia) aegypti (Reed and Carroll, 1902; Reed et al., 1900), and the first flavivirus to be cultivated in vitro (Lloyd et al., 1936). Viruses in the Flavivirus genus are grouped taxonomically into three groups with regard to their vector association and antigenic relationships: (1) tick-borne, (2) mosquito-borne, and (3) viruses with no known arthropod vector (NKV). Within the tick-borne group are two antigenically distinct clades: mammalian and seabird virus groups (Fig. 1). The mammalian group includes several important human pathogens, such as Kyasanur Forest disease (KFDV), Powassan (POWV), Omsk hemorrhagic fever (OHFV), TBEV, and Louping ill viruses (LIV). The mosquito-borne viruses can be divided into groups that principally use Aedes spp. or Culex spp. mosquito vectors. The DENV belong to the former group (Fig. 1). Although the closest relative of the DENV as depicted in this tree is an African virus, Kedougou virus from Senegal, this grouping is not robust and a large group of mosquito-borne viruses from Africa, Asia, and the New World group with DENV with equivalently poor statistical support. Therefore, the current flavivirus tree is not informative as to the probable origins of the DENV.

Figure 1 Phylogenetic tree of the flaviviruses derived from partial NS5 sequences from the GenBank library. Subtypes are written in parentheses after virus names. New World viruses are printed in bold and underlined. The tree was drawn using neighbor joining, and similar topologies were produced using Bayesian methods and maximum parsimony. Numbers indicate bootstrap values for major clades to the right. Reproduced from Hanley & Weaver, 2009, with permission.

Several other members of the mosquito-borne group are the causative agents of severe diseases in humans: St. Louis encephalitis (SLEV), West Nile (WNV), Ilheus (ILHV), Zika (ZIKV), Wesselsbron (WESSV), and YFV. Lastly, within the viruses with no known arthropod vector, there are three antigenically distinct groups: Entebbe bat, Yokose, and Sokoluk viruses group phylogenetically with the mosquito-borne clade, while Modoc-virus and Rio Bravo-like viruses are phylogenetically distinct from the vector-borne groups. Members of these groups have been isolated mainly from bats or rodents and some have been associated with establishment of persistent infections (Baer and Woodall, 1966; Constantine and Woodall, 1964). A handful of these viruses, such as Dakar bat, Modoc, and Rio Bravo, have been isolated from humans in nature (Karabatsos, 1985b; Shope, 2003), or in several laboratory infections probably due to aerosol transmission (Apoi and Rio Bravo virus) (Karabatsos, 1985a; Sulkin et al., 1962). Most common manifestation of human disease from these viruses is febrile illness and rarely encephalitis (Calisher and Gould, 2003; Shope, 2003).

II Dengue Viruses


A Classification of dengue viruses


DENV is considered a species within the genus Flavivirus (family Flaviviridae) and includes four distinct but antigenically related serotypes (DENV-1, -2, -3, and -4) in DEN antigenic complex (Calisher et al., 1989). Of the flaviviruses, DENV are among the most restricted with regard to their natural vertebrate host range, which is believed to include only primates. Currently, all four DENV serotypes can be found in nearly all urban and peri-urban environments throughout the tropics and neotropics where the principal vector, Aedes aegypti, is abundant. This distribution puts at risk of infection nearly a third of the global human population.

Initially, DENV of all serotypes were classified genetically into clusters called topotypes using T1 RNase fingerprinting (Repik et al., 1983; Trent et al., 1990). Later, nucleic acid sequencing allowed for the classification of DENV into genetically distinct groups or genotypes within each serotype (Rico-Hesse, 1990). Rico-Hesse defined these ‘genotypes’ as clusters of DENV viruses having nucleotide sequence divergence not greater than 6% within a given genome region (in this case the E/NS1 junction), which was based on the clustering of strains for which associations could be inferred on epidemiological grounds (Rico-Hesse, 1990).

Various phylogenetic analyses based on partial E/NS1 or complete E nucleotide...

Erscheint lt. Verlag 24.2.2009
Mitarbeit Herausgeber (Serie): Karl Maramorosch, Frederick A. Murphy, Aaron J. Shatkin
Sprache englisch
Themenwelt Sachbuch/Ratgeber
Medizin / Pharmazie Allgemeines / Lexika
Medizin / Pharmazie Medizinische Fachgebiete
Studium Querschnittsbereiche Infektiologie / Immunologie
Naturwissenschaften Biologie Mikrobiologie / Immunologie
Technik
ISBN-10 0-08-092170-1 / 0080921701
ISBN-13 978-0-08-092170-9 / 9780080921709
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 3,7 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 5,3 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Antibiotika, Virostatika, Antimykotika, Antiparasitäre Wirkstoffe

von Hans-Reinhard Brodt; Achim Hörauf; Michael Kresken …

eBook Download (2023)
Thieme (Verlag)
164,99
Mit den neuen Preisen vom 1.10.2023

von Peter M. Hermanns; Enrico Schwartz; Katharina von Pannwitz

eBook Download (2023)
Springer Berlin Heidelberg (Verlag)
59,99